The store will not work correctly when cookies are disabled.
ethyl 6-methoxy-4-(4-methoxyphenylselanyl)quinoline-2-carboxylate
ID: ALA4644482
PubChem CID: 156017728
Max Phase: Preclinical
Molecular Formula: C20H19NO4Se
Molecular Weight: 416.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)c1cc([Se]c2ccc(OC)cc2)c2cc(OC)ccc2n1
Standard InChI: InChI=1S/C20H19NO4Se/c1-4-25-20(22)18-12-19(26-15-8-5-13(23-2)6-9-15)16-11-14(24-3)7-10-17(16)21-18/h5-12H,4H2,1-3H3
Standard InChI Key: CUGLZGYJBPDSIR-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
8.3695 -7.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3683 -8.0149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0831 -8.4277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0813 -6.7748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7967 -7.1838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7975 -8.0107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5128 -8.4217 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2278 -8.0069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2230 -7.1770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5071 -6.7697 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6535 -8.4268 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9393 -8.0137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9349 -6.7601 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6519 -7.1682 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9300 -5.9351 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3639 -6.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.0809 -7.1595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5145 -9.2467 0.0000 Se 0 0 0 0 0 2 0 0 0 0 0 0
11.2299 -9.6577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2281 -10.4804 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9426 -10.8913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6573 -10.4772 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6528 -9.6480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9379 -9.2407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3732 -10.8873 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3760 -11.7123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
2 11 1 0
11 12 1 0
9 13 1 0
13 14 1 0
13 15 2 0
14 16 1 0
16 17 1 0
7 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 416.34 | Molecular Weight (Monoisotopic): 417.0479 | AlogP: ┄ | #Rotatable Bonds: ┄ |
Polar Surface Area: ┄ | Molecular Species: ┄ | HBA: ┄ | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): ┄ | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: ┄ | CX LogD: ┄ |
Aromatic Rings: ┄ | Heavy Atoms: ┄ | QED Weighted: ┄ | Np Likeness Score: ┄ |
References
1. Costa CA, Lopes RM, Ferraz LS, Esteves GNN, Di Iorio JF, Souza AA, de Oliveira IM, Manarin F, Judice WAS, Stefani HA, Rodrigues T.. (2020) Cytotoxicity of 4-substituted quinoline derivatives: Anticancer and antileishmanial potential., 28 (11): [PMID:32336669] [10.1016/j.bmc.2020.115511] |